Australian Patients Report Barriers to Medical Cannabis Access and Treatment
A qualitative research study examining interviews with Australian patients using medical cannabis oil reveals significant barriers to access and treatment continuity. The research highlights patient experiences with therapeutic cannabis but emphasizes that anecdotal patient reports cannot replace rigorous clinical trials in establishing safety and efficacy. Findings underscore the gap between patient-reported benefits and the need for evidence-based clinical data to guide medical cannabis policy and prescription protocols. This study provides valuable insights into real-world patient challenges while reinforcing the importance of continued clinical research to validate medical cannabis applications across various health conditions.
Originally published on
Cannabis Magazine
By Raúl del Pino
Read full article(opens in new tab)Fetched: August 18, 2026 at 10:02 AM

